On Friday, Zynga, Inc. (NASDAQ:ZNGA)’s shares surged 4.62% to $2.49, as a leading provider of social game services, declared that current Chief Executive Officer Don Mattrick departed the Company and the Board of Directors effective April 8, 2015. Mark Pincus, Zynga’s founder and chairman, returned to the role of Chief Executive Officer.
Zynga Inc. develops, markets, and operates online social games as live services played on the Internet, social networking sites, and mobile platforms in the United States, Asia, and Europe.
Advaxis, Inc. (NASDAQ:ADXS)’s shares gained 4.56% to $19.73, during the last trading session on Friday, hitting its highest level, after a clinical stage biotechnology company, declared that its stock has been added to the Loncar Cancer Immunotherapy Index (LCINDX). Based on current allocations and current share prices, Advaxis is the most heavily weighted stock in LCINDX.
The Loncar Cancer Immunotherapy Index (LCINDX), produced by Loncar Investments, LLC, is the first professional index to track the transformational immunotherapy field within the biotechnology space. LCINDX seeks to track the performance of a basket of companies that develops therapies to treat cancer by harnessing the body’s own immune system. The index will provide a metric to follow its progress as researchers advance new technologies for the benefit of patients who fight cancer disease. LCINDX is an index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in immunotherapy.
LCINDX is a professional index of 25 top immunotherapy companies rebalanced and reconstituted on a semi-annual basis. Of the 25 holdings, six are large pharma companies and 19 are growth biotech companies.
Gregory T. Mayes, Executive Vice President & COO of Advaxis, commented, “We are very happy that Advaxis has been comprised of in the inaugural Loncar Cancer Immunotherapy Index as it should serve to bring even greater investor interest to our company and the broader immunotherapy industry.”
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor.
At the end of Friday’s trade, DexCom, Inc. (NASDAQ:DXCM)’s shares gained 4.45% to $67.89, hitting its highest level, as a medical device company, declared that it plans to release its first quarter 2015 financial results after market close on Wednesday, April 29, 2015. Administration will hold a conference call to review the company’s first quarter 2015 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be accessible on the DexCom, Inc. website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and then “Events and Webcasts,” and will be archived there for future reference.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes.
Finally, XPO Logistics, Inc. (NYSE:XPO), ended its Friday’s trading session with 4.43% gain, and closed at $45.48, as XPO will hold its first quarter conference call and webcast on Tuesday, May 5, 2015, at 8:30 a.m. Eastern Time. The company`s results will be released after market close on May 4 and made accessible on www.xpo.com.
XPO Logistics, Inc. provides transportation and logistics services primarily in the United States. The company operates through two segments, Transportation and Logistics. The Transportation segment provides truckload, less-than truckload and intermodal brokerage, and last-mile delivery logistics services under the brands XPO Logistics, XPO Last Mile, and Pacer; and time-critical, time-sensitive, or high priority freight shipment services under the brand names XPO Express, XPO NLM, and XPO Air Charter
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
